Delivery Order SPE2DB22D3501-SPE2DB23FXF89
Award Date 9/18/23
Potential Completion Date 10/10/23
Potential Value $42K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $14,122 delivery order to Amerisourcebergen Drug Corporation for 4562106623 REVLIMID 10 MG CAPSULE 28S. The firm fixed price order is being fulfilled under an existing Prime Vendor Pharmaceutical contract vehicle and will provide the specified pharmaceutical products to DLA from Amerisourcebergen's facility in Conshohocken, Pennsylvania. Performance will take place between September 8 and September 29, 2023. No set aside designation or subcontractors were...
- The Defense Logistics Agency awarded a $161,868.57 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562336109 REVLIMID 10 MG CAPSULE 100S. The delivery order is being carried out under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of Department of Defense health programs. Performance will take place in Conshohocken, Pennsylvania over a period of one month concluding on October 19, 2023. No subcontractors or...
- The Defense Logistics Agency awarded a $14,122.63 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561750571 REVLIMID 10 MG CAPSULE 28S. This order was placed under an existing Prime Vendor contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the specified pharmaceutical to its Conshohocken, Pennsylvania facility by August 29, 2023 to support DOD health programs. No set...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $28,245.28 to Amerisourcebergen Drug Corporation for the provision of 4561508525 REVLIMID 10 MG CAPSULE 28S. The contract has a period of performance from July 13, 2023 through August 3, 2023, with all work to be conducted by the prime contractor at its facility located in Conshohocken, Pennsylvania. This delivery order was issued against an existing DLA vehicle to support the procurement of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $373,171.40 to Amerisourcebergen Drug Corporation for the provision of 4562106624 REVLIMID 10 MG CAPSULE 100S. The firm fixed price order calls for the delivery of pharmaceutical products to a facility located in Conshohocken, Pennsylvania by September 29, 2023 in support of Department of Defense requirements. Amerisourcebergen will serve as the prime contractor on the order placed under an unspecified multiple award contract...
- The Defense Logistics Agency awarded a $14,122.63 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 28 capsules of the pharmaceutical Revlimid 10 mg. The order is being fulfilled under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the Revlimid capsules to a facility in Conshohocken, Pennsylvania by September 12, 2023 to support DLA and DoD medical readiness...
- The Defense Logistics Agency awarded a $28,245.28 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561527539 REVLIMID 10 MG CAPSULE 28S. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 4, 2023 under the terms of the order. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for worldwide logistics...
- The Defense Logistics Agency awarded a $157,346 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 100 capsules of the pharmaceutical Revlimid 5 mg. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one month period concluding in mid-October 2023. No...
- The Defense Logistics Agency awarded a $28,245 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561632369 REVLIMID 10 MG CAPSULE 28S. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 17, 2023 in support of the Defense Logistics Agency's medical supply chain programs. No subcontractors or set aside designations were identified in the award...
- Defense Logistics Agency awarded a $42,367.89 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, on October 20, 2023. The contract calls for the delivery of REVLIMID 10 MG CAPSULE 28S to Conshohocken, Pennsylvania by November 13, 2023. No set-aside designation was used for this procurement. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this award will help the Defense Logistics Agency...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FXF89Delivery Order
The Defense Logistics Agency awarded a $42,368 delivery order to Amerisourcebergen Drug Corporation for the supply of 4562224020 REVLIMID 10 MG CAPSULE 28S. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to provide pharmaceutical products in support of DLA and DoD health programs. Performance will take place in Conshohocken, Pennsylvania over a one month period concluding in early October 2023. No subcontractors or set aside designations were indicated. The award continues DLA's procurement of essential prescription medications through its prime vendor relationships.
Generated 12/18/23, 1:30 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.4k | 9/18/23 |